Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marianne A Mihalyo

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|September 24, 2002
Effector CD4 cells are tolerized upon exposure to parenchymal self-antigenAmy D Higgins, Marianne A Mihalyo, Adam J Adler
Cellular Immunology|November 12, 2003
Effector CD4 cell tolerization is mediated through functional inactivation and involves preferential impairment of TNF-alpha and IFN-gamma expression potentialsMeixiao Long, Amy D Higgins, Marianne A Mihalyo, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 23, 2002
CD4 cell priming and tolerization are differentially programmed by APCs upon initial engagementAmy D Higgins, Marianne A Mihalyo, Patrick W McGary, et al.
The Prostate|January 16, 2007
Dendritic cells program non-immunogenic prostate-specific T cell responses beginning at early stages of prostate tumorigenesisMarianne A Mihalyo, Adam T Hagymasi, Aaron M Slaiby, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 7, 2004
Glycoprotein 96 can chaperone both MHC class I- and class II-restricted epitopes for in vivo presentation, but selectively primes CD8+ T cell effector functionAmy D H Doody, Joseph T Kovalchin, Marianne A Mihalyo, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 21, 2007
Steady state dendritic cells present parenchymal self-antigen and contribute to, but are not essential for, tolerization of naive and Th1 effector CD4 cellsAdam T Hagymasi, Aaron M Slaiby, Marianne A Mihalyo, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 6, 2006
T-bet down-modulation in tolerized Th1 effector CD4 cells confers a TCR-distal signaling defect that selectively impairs IFN-gamma expressionMeixiao Long, Aaron M Slaiby, Adam T Hagymasi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2004
In vivo cyclophosphamide and IL-2 treatment impedes self-antigen-induced effector CD4 cell tolerization: implications for adoptive immunotherapyMarianne A Mihalyo, Amy D H Doody, Jeremy P McAleer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 6, 2009
The E3 ubiquitin ligase Cbl-b regulates expansion but not functional activity of self-reactive CD4 T cellsMarie-Clare St Rose, Harry Z Qui, Suman Bandyopadhyay, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 20, 2007
Histone acetylation at the Ifng promoter in tolerized CD4 cells is associated with increased IFN-gamma expression during subsequent immunization to the same antigenMeixiao Long, Aaron M Slaiby, Shuang Wu, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Journal of Immunology (Baltimore, Md. : 1950)|September 24, 2002
Effector CD4 cells are tolerized upon exposure to parenchymal self-antigenAmy D Higgins, Marianne A Mihalyo, Adam J Adler
Cellular Immunology|November 12, 2003
Effector CD4 cell tolerization is mediated through functional inactivation and involves preferential impairment of TNF-alpha and IFN-gamma expression potentialsMeixiao Long, Amy D Higgins, Marianne A Mihalyo, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 23, 2002
CD4 cell priming and tolerization are differentially programmed by APCs upon initial engagementAmy D Higgins, Marianne A Mihalyo, Patrick W McGary, et al.
The Prostate|January 16, 2007
Dendritic cells program non-immunogenic prostate-specific T cell responses beginning at early stages of prostate tumorigenesisMarianne A Mihalyo, Adam T Hagymasi, Aaron M Slaiby, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 7, 2004
Glycoprotein 96 can chaperone both MHC class I- and class II-restricted epitopes for in vivo presentation, but selectively primes CD8+ T cell effector functionAmy D H Doody, Joseph T Kovalchin, Marianne A Mihalyo, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 21, 2007
Steady state dendritic cells present parenchymal self-antigen and contribute to, but are not essential for, tolerization of naive and Th1 effector CD4 cellsAdam T Hagymasi, Aaron M Slaiby, Marianne A Mihalyo, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 6, 2006
T-bet down-modulation in tolerized Th1 effector CD4 cells confers a TCR-distal signaling defect that selectively impairs IFN-gamma expressionMeixiao Long, Aaron M Slaiby, Adam T Hagymasi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2004
In vivo cyclophosphamide and IL-2 treatment impedes self-antigen-induced effector CD4 cell tolerization: implications for adoptive immunotherapyMarianne A Mihalyo, Amy D H Doody, Jeremy P McAleer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 6, 2009
The E3 ubiquitin ligase Cbl-b regulates expansion but not functional activity of self-reactive CD4 T cellsMarie-Clare St Rose, Harry Z Qui, Suman Bandyopadhyay, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 20, 2007
Histone acetylation at the Ifng promoter in tolerized CD4 cells is associated with increased IFN-gamma expression during subsequent immunization to the same antigenMeixiao Long, Aaron M Slaiby, Shuang Wu, et al.
Pageof 2